GROUP ONE TRADING, L.P. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 134 filers reported holding PDL BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2019$24,000
+2300.0%
7,500
+2852.8%
0.00%
Q4 2018$1,000
-80.0%
254
-84.7%
0.00%
Q1 2018$5,000
-16.7%
1,662
-23.1%
0.00%
Q4 2017$6,000
-78.6%
2,162
-74.0%
0.00%
Q3 2017$28,000
+180.0%
8,311
+107.2%
0.00%
Q2 2017$10,000
-65.5%
4,011
-68.9%
0.00%
Q1 2017$29,000
-31.0%
12,911
-35.3%
0.00%
Q4 2016$42,000
+2.4%
19,959
+52.0%
0.00%
Q2 2016$41,000
-47.4%
13,127
-44.0%
0.00%
-100.0%
Q1 2016$78,000
+212.0%
23,427
+233.4%
0.00%
Q4 2015$25,000
-16.7%
7,027
+16.6%
0.00%
Q3 2015$30,000
-71.2%
6,027
-62.6%
0.00%
-100.0%
Q2 2015$104,000
-22.4%
16,127
-15.2%
0.00%
-50.0%
Q1 2015$134,000
+378.6%
19,016
+433.1%
0.00%
Q4 2014$28,000
-65.9%
3,567
-67.5%
0.00%
-100.0%
Q3 2014$82,000
+241.7%
10,971
+262.9%
0.00%
Q3 2013$24,000
-74.2%
3,023
-74.9%
0.00%
-100.0%
Q2 2013$93,00012,0450.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
KESTREL INVESTMENT MANAGEMENT CORP 1,465,000$3,853,0001.56%
SMH CAPITAL ADVISORS INC 93,708$246,0000.42%
West Family Investments, Inc. 627,800$1,651,0000.39%
KENNEDY CAPITAL MANAGEMENT LLC 7,082,858$18,628,0000.35%
ARMISTICE CAPITAL, LLC 1,800,000$4,734,0000.28%
BRANDES INVESTMENT PARTNERS, LP 3,936,719$10,354,0000.23%
ROCKY MOUNTAIN ADVISERS, LLC 14,300$38,0000.13%
Zebra Capital Management LLC 74,695$196,0000.09%
Connor, Clark & Lunn Investment Management Ltd. 5,968,105$15,696,0000.09%
CREDIT AGRICOLE S A 471,644$1,240,0000.06%
View complete list of PDL BIOPHARMA INC shareholders